Global Optic Neuropathy Therapeutics Pipeline Review 2016: 7 Companies & 14 Molecules – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Optic Neuropathy - Pipeline Review, H2 2016" report to their offering. Optic Neuropathy pipeline therapeutics constitutes close to 14 molecules. Out of which approximately 8 molecules are developed by Companies and remaining by the Universities/Institutes. The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1, 4 and 1 respectively. Similarly, the Universi
